Satyajit Tripathy | Nanodrug | Distinguished Scientist Award

Published on by Academic Achievements

Dr. Satyajit Tripathy | Nanodrug | Distinguished Scientist Award

Dr. Satyajit Tripathy | Nanodrug | Assistant Professor at Amity University, India

Dr. Satyajit Tripathy is a distinguished academic and researcher in the field of Human Physiology, specializing in Microbiology and Immunology. He holds an M.Sc. in Human Physiology with specialization in Microbiology and Immunology from Vidyasagar University and a Ph.D. in Physiology from the same institution, where his doctoral research focused on the antimalarial efficacy of chitosan nanoparticle-conjugated chloroquine against Plasmodium berghei, demonstrating pioneering work in nanomedicine. Dr. Tripathy has extensive professional experience as an Assistant Professor at Amity University, Noida, and Chandigarh University, and has contributed as a guest lecturer and senior lecturer at multiple Indian and international institutions, including the University of the Free State, South Africa, and Michigan State University, USA. His research interests encompass antimalarial therapies, anticancer nanoparticles, immunomodulation, and translational biomedical applications, with skills in molecular biology, nanoparticle synthesis, immunoassays, and preclinical model evaluation. He has led and participated in numerous international research projects and has a strong record of publications in high-impact journals, with a total citation count exceeding 2,500, h-index of 27, and i10-index of 47. Dr. Tripathy has been recognized for his contributions through awards, honors, and leadership roles in academic and research communities, actively participating in professional societies such as IEEE and ACM. His work demonstrates a commitment to scientific excellence, innovation, mentorship, and collaborative research. In conclusion, Dr. Satyajit Tripathy exemplifies an accomplished researcher and educator whose expertise, global research experience, and dedication to advancing human physiology and biomedical sciences make him a valuable contributor to the scientific community with significant potential for future impact.

Profile: Google Scholar | Scopus

Featured Publications

  1. Erukainure, O. L., Chukwuma, C. I., Nambooze, J., Tripathy, S., Salau, V. F., Olofinsan, K., Ogunlakin, A. D., Ebuehi, O. A. T., & Unuofin, J. O. (2025). Tea Consumption and Diabetes: A Comprehensive Pharmacological Review of Black, White, Green, Oolong, and Pu-erh Teas. Plants. 15 citations.

  2. Nina, N., Burgos-Edwards, A., Theoduloz, C., Tripathy, S., Matsabisa, M. G., & Schmeda-Hirschmann, G. (2024). Chemical Profiling, Enzyme Inhibitory Activity and Antioxidant Capacity of South African Herbal Teas: Buddleja saligna, Lippia javanica, L. scaberrima and Phyla dulcis. Antioxidants. 12 citations.

  3. Bhattacharya, D., Mukhopadhyay, M., Shivam, K., Tripathy, S., Patra, R., & Pramanik, A. (2023). Recent Developments in Photodynamic Therapy and Its Application Against Multidrug Resistant Cancers. Biomedical Materials. 10 citations.

  4. Mutombo, P. N., Kasilo, O. M., James, P. B., Wardle, J., Kunle, O., Katerere, D., Wambebe, C., Matsabisa, M. G., Rahmatullah, M., Nikiema, J. B., Mukankubito, I., Sheridan, R., Sanogo, R., Nissapatorn, V., Sivakorn, C., Tripathy, S., & Goyal, R. (2023). Experiences and Challenges of African Traditional Medicine: Lessons from COVID-19 Pandemic. BMJ Global Health. 18 citations.

  5. Mukherjee, P., Tripathy, S., Matsabisa, M. G., & Sahu, S. K. (2022). Development of Upconversion-NMOFs Nanocomposite Conjugated with Gold Nanoparticles for NIR Light-Triggered Combinational Chemophotothermal Therapy. Journal of Photochemistry & Photobiology, A: Chemistry. 14 citations.

  6. Das, S., Tripathy, S., Das, A., Sharma, M. K., Nag, A., Hati, A. K., & Roy, S. (2022). Genomic Characterization of Plasmodium falciparum Genes Associated with Anti-Folate Drug Resistance and Treatment Outcomes in Eastern India: A Molecular Surveillance Study. Frontiers in Cellular and Infection Microbiology. 16 citations.

  7. Matsabisa, M. G., Bala, A., Tripathy, S., Diganshu, M. M., Rautenbach, F. G., & Dassarma, B. (2022). Study on South African Indigenous Teas – Antioxidant Potential, Nutritional Content and Hypoxia-Induced Cyclooxygenase Inhibition on U87 MG Cell Line. Molecules. 11 citations.

 

Shymaa Hatem | Pharmaceutics and Pharmaceutical Technology | Women Researcher Award

Published on by Academic Achievements

Assist Prof. Dr.Shymaa Hatem | Pharmaceutics and Pharmaceutical Technology | Women Researcher Award

Assistant Professor at Future University in Egypt

Dr. Shymaa Hatem Abdel-Azeem is a distinguished academic and researcher in the field of pharmaceutics and pharmaceutical technology. She currently serves as a Lecturer at the Faculty of Pharmacy, Future University in Egypt. With over a decade of academic experience, she has contributed significantly to pharmaceutical research, focusing on advanced drug delivery systems and nanotechnology-based therapies for dermatological conditions. Dr. Shymaa is recognized for her leadership in various academic and professional organizations, contributing to the advancement of pharmaceutical sciences and women’s empowerment in the Arab world.

Profile:

Google Scholar

Education:

Dr. Shymaa earned her Ph.D. in Pharmaceutical Sciences (Pharmaceutical Technology) from Ain Shams University in June 2022. Her doctoral research focused on the “Preparation and Evaluation of Topical Nanoformulations for the Treatment of Melasma.” She holds an M.Sc. in Pharmaceutical Sciences (Pharmaceutics) from Ain Shams University, completed in 2018, where her thesis examined “Preparation and Characterization of Topical Antioxidant Formulations.” In 2010, she graduated with a B.Sc. in Pharmaceutical Sciences and Pharmaceutical Industries from Cairo University, achieving an overall grade of “Excellent.”

Experience:

Dr. Shymaa has been a key academic figure at Future University in Egypt since 2012. Starting as a Teaching Assistant in the Department of Pharmaceutics and Pharmaceutical Technology, she progressed to Assistant Lecturer and eventually to her current position as Lecturer. She is also a member of the Consulting Staff at several organizations, including the International Arab-African Council for Diplomatic Relations and Peace between Nations, and the Egyptian Association of Continuing Medical Education Development. In 2023, she was certified as an expert in Arabic women’s issues by the International Leadership Center.

Research Interest:

Dr. Shymaa’s research interests are centered around the development of innovative drug delivery systems, with a special focus on nanotechnology. Her work emphasizes the formulation of topical treatments for dermatological conditions such as melasma, psoriasis, and acne. She also explores the application of nanostructured lipid carriers and vesicular systems for the enhanced delivery of active pharmaceutical ingredients to the skin and brain. Her goal is to enhance the clinical efficacy of drugs using novel pharmaceutical technologies.

Awards:

Throughout her career, Dr. Shymaa has earned recognition for her contributions to the field of pharmaceutical sciences. In 2024, she completed the Training of Trainers (TOT) program from Ain Shams University, which certified her as a professional trainer. Her leadership and active participation in community services, particularly in women’s empowerment, have also been acknowledged by various professional organizations.

Publications:

Dr. Shymaa has published extensively in high-impact journals, with her research widely cited within the scientific community. Below are selected publications, complete with links and journal details:

“Clinical Cosmeceutical Repurposing of Melatonin in Androgenic Alopecia Using Nanostructured Lipid Carriers Prepared with Antioxidant Oils” (2018). Published in Expert Opinion on Drug Delivery and cited by 62 articles. Link to paper.

“Melatonin Vitamin C-based Nanovesicles for Treatment of Androgenic Alopecia: Design, Characterization, and Clinical Appraisal” (2018). Published in European Journal of Pharmaceutical Sciences and cited by 48 articles. Link to paper.

“Recent Advances in Antioxidant Cosmeceutical Topical Delivery” (2018). Published in Current Drug Delivery and cited by 36 articles. Link to paper.

“Background and Different Treatment Modalities for Melasma: Conventional and Nanotechnology-Based Approaches” (2020). Published in Journal of Drug Delivery Science and Technology and cited by 25 articles. Link to paper.

“Functionalized Chitosan Nanoparticles for Cutaneous Delivery of a Skin Whitening Agent: An Approach to Clinically Augment the Therapeutic Efficacy for Melasma Treatment” (2022). Published in Drug Delivery and cited by 14 articles. Link to paper.

“Optimization of the Colloidal Properties of Chitosan Nanoparticles Encapsulating Alpha-Arbutin” (2022). Published in Archives of Pharmaceutical Sciences Ain Shams University and cited by 8 articles. Link to paper.

“Novel Anti-Psoriatic Nanostructured Lipid Carriers for the Cutaneous Delivery of Luteolin: A Comprehensive In-Vitro and In-Vivo Evaluation” (2023). Published in European Journal of Pharmaceutical Sciences and cited by 5 articles. Link to paper.

Conclusion:

Shymaa Hatem Abdel-Azeem is a highly competent researcher with notable achievements in pharmaceutical nanotechnology and drug delivery systems. Her leadership roles and academic contributions, especially to women’s issues in the Arab world, underscore her qualifications for the “Research for Women Researcher Award.” By continuing to grow her international collaborations, expanding her research focus, and securing further funding, she can further solidify her standing as an influential figure in her field.